Analyze independently with AI, no credit card required.

Start Free Trial
Pharma Persona Roster

Competitive Share Shift Agent

A pharma competitive intelligence agent that watches branded, generic, and competitor prescribing at the HCP, territory, and market level. Part of the Pharma Commercial Analytics agent roster, grounded in QuaerisAI's certified semantic layer.

Get guided setup
Territory AnalysisTrend View
TERRITORY 14 · COMPETITIVE SHARE ANALYSIS
Region: Northeast · Period: Current cycle · Powered by QuaerisAI Agentic Engine
Competitor B share shift+7.2 pts
SegmentHigh-potential psychiatrists
SourcePrescribing, territory, market data
Definition usedCertified, v2.3

Certified competitive intelligence across every territory

The Competitive Share Shift Agent runs share shift analysis on branded, generic, and competitor prescribing at the HCP, territory, and market level, so a change in prescribing behavior surfaces on its own rather than waiting for someone to notice it in a quarterly review. This is what life sciences competitive intelligence looks like when it is built into the same governed pipeline as the rest of your analytics, not assembled by hand from separate reports.

Results are presented alongside the source data behind them: which prescribing records, which territory definition, and which certified metric version produced the figure. That means a commercial analytics director can trust the number without re-deriving it, and can trace it back if a field team challenges it.

Territory List
TERRITORIES WITH SIGNIFICANT SHARE MOVEMENT
Territory 14, NortheastCompetitor B +7.2 pts
Territory 22, MidwestBranded +3.1 pts
Territory 09, SoutheastGeneric +4.6 pts

Benefits

This agent helps commercial analytics teams track competitive movement faster and act on it with more confidence.

  • Time efficiency: Reduce competitive review time from a manual quarterly process to a continuously monitored one.
  • Consistent definitions: Every territory is evaluated against the same certified prescribing and share definitions.
  • Traceable answers: Every figure cites the source data and metric version behind it.
  • Governed access: Field and regional teams only see the territories their role is permitted to access.
  • Earlier signal: Share shifts surface as they happen instead of at the next scheduled review.
  • Consistent methodology: The same analytical logic applies whether the question comes from a rep, a director, or an executive.

Problem addressed

Tracking competitive share shifts across dozens or hundreds of territories is traditionally a manual process: pulling prescribing data, reconciling it against territory definitions that may differ by team, and waiting for a scheduled business review to notice a shift has already happened. Competitor profiling done this way is slow by design, since it depends on someone remembering to compile it. By the time a change is flagged, a competitor may have already gained meaningful ground with a specific prescriber segment.

The Competitive Share Shift Agent replaces that manual review with a continuously governed one, so a shift in prescribing behavior is available to ask about as soon as the underlying data reflects it, not at the next quarterly cycle.

What the agent does

  • Monitors branded, generic, and competitor prescribing at the HCP, territory, and market level
  • Applies certified definitions for share, segment, and territory consistently across every query
  • Surfaces significant share movement without waiting for a scheduled review
  • Cites the source prescribing data and metric version behind every figure
  • Enforces role-based access, so a rep sees their territory and a director sees their region

Why do this with AI

Prescribing data across a large territory footprint is high in volume and easy to review inconsistently when it is done manually by different analysts on different schedules. An agent grounded in a certified semantic layer applies the same definition of share, segment, and territory every time, regardless of who is asking or when, which is the difference between pharma market intelligence that is genuinely current and a report that was accurate when someone last pulled it.

Instead of spending time compiling and reconciling territory-level reports, commercial analytics teams can spend that time deciding what to do about a shift once it is flagged.

Root Cause
ROOT CAUSE SIGNALS · TERRITORY 14
Call frequency to high-potential HCPsBelow target
Sample allocation vs. competitorLower share of voice
Days since last rep contact (top decile)41 days

Who this agent is for

  • Reduce manual competitive reporting and reconciliation
  • Compare share movement consistently across every territory
  • Identify root causes behind a share shift faster
  • Surface competitive risk earlier than the next scheduled review
  • Make field engagement decisions with a traceable, certified number
Ideal for: commercial analytics directors, field sales leadership, brand teams, and market access teams in pharma commercial organizations.

How it works

The agent resolves each question through the same governed pipeline as every other QuaerisAI agent: identity and permissions are checked first, the question is mapped to certified definitions, a governed query runs against the source data, and the result is returned with a full audit record attached.

01Question asked
02Identity & permissions checked
03Certified definition applied
04Governed query runs
05Source-backed answer returned
06Audit record written
A deterministic governance pipeline wraps every step the agent takes, from question to answer.

Frequently asked questions

A dedicated QuaerisAI agent that monitors branded, generic, and competitor prescribing at the HCP, territory, and market level, grounded in certified definitions so every user gets a consistent answer.